Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella

Last 30 days: 231 accesses
Last 365 days: 2394 accesses
All time: 8189 accesses

Jerome S Harms^*, Marina A Durward, Diogo M Magnani and Gary A Splitter

Journal of Immune Based Therapies and Vaccines 2009, 7:1 doi:10.1186/1476-8518-7-1

Accesses